Näidustused võrkkesta laserkoagulatsiooni kohta diabeetilise retinopiga
What is diabetic retinopathy? Diabetic retinopathy is an eye problem that can be caused by either type 1 or type 2 diabetes mellitus. Retinopathy occurs when diabetes damages the tiny blood vessels in the retina. The weakened blood vessels may leak fluid and blood. Who are at risk for developing diabetic retinopathy.
Kui teil tekib hommikul diabeet
To determine the outcome of central retinal vein occlusion (CRVO) in pre-existing glaucoma and the predisposing factors of developing neovascular glaucoma (NVG). We retrospectively assessed a pre-existing glaucoma CRVO group and a non-glaucoma CRVO group to elucidate the demographics, clinical course and ocular parameters of these two cohorts.
You may look:-> Pähklid veresuhkru alandamiseks
webeye.ophth.uiowa.edu.
-> Diabetes mellitusega haige jalad võivad masseerida
This observational study is intended to collect outcome data from a cohort of 30 patients suffering from dry eye disease due to chronic ocular Graft-versus-Host Disease (GvHD) who are treated with the medical device NovaTears® eye drops for a duration of 11 to 13 weeks.
-> Mis vähendab suhkrut diabeedi korral
Prepare to become a physician, build your knowledge, lead a health care organization, and advance your career with NEJM Group information and services. The authorized source of trusted medical.
-> Kuidas teha kindlaks, et inimene on diabeediga haige
This is a phase I/IIa, randomized, double-blind, two-arms, two-dose administration, placebo controlled, two-way crossover clinical trial in which 10 patients from 18 to 65 years of age affected with chronic traumatic spinal cord will enter the study with the objective to assess the safety and to obtain efficacy data in intrathecal administration of expanded Wharton s jelly mesenchymal stem cells.
-> Diabeediga patsientide meditsiiniline kliiniline läbivaatus
Published 12 August 2005 Intravitreal Triamcinolone For Retinal Vein Occlusions Results from small-scale studies are good, but the findings of a large-scale, randomized, prospective trial would be even better.
Näidustused võrkkesta laserkoagulatsiooni kohta diabeetilise retinopiga:
Rating: 52 / 801
Overall: 951 Rates